A Study of Golimumab in Participants With Active Ankylosing Spondylitis
Status:
Completed
Trial end date:
2016-10-11
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of intravenously (administration of a
fluid into the vein) administered golimumab 2 milligram per kilogram (mg/kg) in participants
with active ankylosing spondylitis (chronic inflammatory disease of unknown etiology that
involves the sacroiliac joints, and often the axial skeleton, entheses, and peripheral
joints).